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S U M M A R Y
The case of a 74-year-old woman who presented with hyperthermia and hypotension is reported.
Laboratory test results revealed marked elevation of C-reactive protein (CRP) and procalcitonin (PCT)
levels. The clinical presentation and laboratory test results were suggestive of septic shock. No infectious
focus was identiﬁed. The shock recurred after what was subsequently understood to be an unintended
re-challenge with risedronate sodium. Drug-induced anaphylactic shock was ﬁnally diagnosed.
Anaphylactic shock may be misdiagnosed as septic shock in patients who present with markedly
elevated PCT levels.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Procalcitonin (PCT) is a useful biomarker for the early diagnosis
of sepsis in critically ill patients. However, serum PCT levels may be
very high in patients with systemic inﬂammation without
infection.1 The case of a patient who presented with hyperthermia
and hypotension, along with elevated C-reactive protein (CRP) and
PCT levels is reported. The clinical presentation and laboratory test
results were suggestive of septic shock. The markedly elevated CRP
and PCT levels on admission led to the misdiagnosis of
anaphylactic shock as septic shock.
2. Case report
A 74-year-old woman was referred to the emergency room (ER)
with suspected septic shock. She had initially presented to a local
clinic with the primary complaint of acute fever, and her systolic
blood pressure was found to be <60 mmHg; she was promptly
transferred to our hospital.
The patient had a 3-day history of nausea, with fever and chills.
Her vital signs were as follows: systolic blood pressure 70 mmHg,
pulse rate 104 beats/min, respiratory rate 22 breaths/min, and
body temperature 38.0 8C. A vasopressor agent (norepinephrine)
was administered to maintain the systolic blood pressure at* Corresponding author. Tel.: +82-63-859-2647; fax: +82-63-855-2025.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).>90 mmHg. The patient appeared acutely ill, but physical
examination ﬁndings were normal, except for mild epigastric
tenderness. She had no rash. She had undergone a gastrectomy for
gastric cancer 11 years previously, and surgery for a pituitary
tumor 5 years previously. Laboratory test results revealed a white
blood cell (WBC) count of 6.47  109/l (neutrophils, 63%),
hemoglobin level of 11.4 g/dl, a platelet count of 232  109/l,
serum blood urea nitrogen level of 52 mg/dl, and serum creatinine
level of 1.43 mg/dl. The erythrocyte sedimentation rate (ESR) was
30 mm/h, but CRP and PCT levels were markedly elevated at
262 mg/l and 168 ng/ml, respectively.
Based on the presumptive diagnosis of sepsis, the patient
received broad-spectrum antibiotics (a combination of cefotaxime
and amikacin). Her vital signs stabilized 25 h after admission to the
hospital, and she was considered to have recovered from shock. On
day 3 of hospitalization, the CRP and PCT levels decreased to
79 mg/l and 22.4 ng/ml, respectively. Blood culture, urine culture,
and stool culture from samples obtained on admission to the ER
showed no microorganism growth. Chest and abdominal comput-
ed tomography were performed in the hope of detecting the
primary focus of her septic shock, but the results revealed no
unusual ﬁndings. She received parenteral antibiotics for 8 days,
and was discharged with oral antibiotics. The patient received
15 days of antibiotic therapy in total.
After 2 weeks, the patient had no symptoms, and laboratory test
results were within the normal ranges. However, 9 days later, the
patient was re-admitted to the ER with a fever and chills. Her vital
signs were as follows: systolic blood pressure 70 mmHg, pulse rateciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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temperature 39.9 8C. The patient appeared acutely ill and
complained of nausea and vomiting. Laboratory test results
revealed a WBC count of 6  109/l (neutrophils, 85.6%), hemoglobin
level of 11.5 g/dl, platelet count of 232  109/l, and ESR of 18 mm/
h. The CRP and PCT levels were elevated at 169 mg/l and 42.3 ng/
ml, respectively.
Following a patient interview, it was strongly suspected that
the two episodes of septic shock were closely related to the intake
of medicine prescribed for the treatment of osteoporosis. The
patient had been admitted to the hospital for the ﬁrst time 3 days
after her ﬁrst dose of risedronate sodium (Actonel 150 mg once-a-
month), which caused her to develop a fever with chills. She was
admitted for the second time after she had self-administered
risedronate sodium that was a scheduled monthly dose, which
again led to a fever with chills. The patient’s clinical course was
very similar to that of the previous event; the fever lasted for 3 days
and the shock continued for 4 days. On admission to the ER,
samples were collected for blood culture, urine culture, and stool
culture, including the test for Clostridium difﬁcile; however, there
was no growth of any microorganism. On day 4 of re-hospitaliza-
tion, her vital signs stabilized and her symptoms began to improve.
The patient was discharged 7 days after re-hospitalization. One
week later, the patient had no symptoms, and laboratory test
results had returned to normal. Risedronate sodium was discon-
tinued, and no similar episodes were noted during the 12-month
follow-up period.
3. Discussion
In this case, the patient presented with hyperthermia and
hypotension, along with elevated CRP and PCT levels that were
initially suggestive of septic shock. However, the diagnosis was
subsequently changed to an anaphylactic reaction to risedronate
sodium (Actonel) after an unintended re-challenge.2 Although ahigh PCT commonly occurs in infection, dramatic PCT level
elevation may also accompany many other conditions, including
multiple organ dysfunction syndrome, trauma, severe pancreatitis,
rhabdomyolysis, hypovolemic and cardiogenic shock, and burns.1
It was recently reported that anaphylaxis triggered by drug
exposure can also induce a marked elevation in PCT levels.3,4 In a
meta-analysis, PCT had low positive predictive values (17–28%)
and high negative predictive values (95–98%) at the 0.5 ng/ml cut-
off for bacteremia in adult patients suspected of infection or sepsis.
Low PCT levels could be used to rule out bacteremia in different
clinical settings.5
In the present case, the patient was initially diagnosed with
septic shock, rather than anaphylactic shock, due to the markedly
elevated CRP and PCT levels, and the shock recurred after an
unintended re-challenge. In the setting of critical illness and shock,
PCT may be better interpreted as a marker that is reﬂective of
overall inﬂammation. Drug-induced anaphylaxis should be con-
sidered a potential cause of PCT elevation in the absence of severe
bacterial infection.
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